877 filings
Page 10 of 44
8-K
u360p mxqi31mlbcnoi
9 Dec 19
Windtree Therapeutics Completes $26.4 Million Private Placement
5:09pm
8-K
p6152xhy
28 Oct 19
Entry into a Material Definitive Agreement
4:40pm
8-K
0ta4b3ry 73p
25 Oct 19
Windtree Therapeutics Provides Business Update
5:17pm
8-K
oh5ndp9xxzocefu
14 Aug 19
Windtree Therapeutics Reports Second Quarter 2019 Financial Results and Provides Key Business Updates
12:00am
DEF 14C
cphbxclffra09s
18 Jul 19
Information statement
4:49pm
UPLOAD
uf1lfc 72bkwiojcu
18 Jul 19
Letter from SEC
12:00am
PRER14C
kyf4drw nbbaao
17 Jul 19
Preliminary revised information
5:29pm
CORRESP
q3gcelujjhlx6d90bx
17 Jul 19
Correspondence with SEC
12:00am
UPLOAD
9vdd0qkhb9i7ajf7a0q
3 Jul 19
Letter from SEC
12:00am
PRE 14C
hkeqz5i
24 Jun 19
Preliminary information
4:25pm
8-K
u6tkt115y btkfhw7
31 May 19
Istaroxime Phase 2b Study Results Presented in Late Breaker Clinical Trial Session at the ESC Heart Failure Congress
4:17pm
NT 10-Q/A
p4tmukejjql3ru1u9
16 May 19
Notice of late quarterly filing (amended)
9:46pm
EFFECT
h0cv qyeiznloiem
16 May 19
Notice of effectiveness
12:15am
NT 10-Q
5yl 3ghikj2klmd
15 May 19
Notice of late quarterly filing
4:34pm
CORRESP
qbr5focl9uz awhir
15 May 19
Correspondence with SEC
12:00am
UPLOAD
r0jkeks1 kqd3x14b7b
7 May 19
Letter from SEC
12:00am
8-K
hr5 drot1jao8ypbhcd
30 Apr 19
Windtree Therapeutics Appoints Daniel Geffken to Board of Directors
4:26pm